Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Absa Group Limited | AU61 | Apr 17, 2025 | 7.85 | +2.61 |
ABSOLICON SOLAR COLLEC. B | ZY0 | Apr 17, 2025 | 0.26 | -2.66 |
AC Immune SA | IMR | Apr 17, 2025 | 1.26 | -3.98 |
Acacia Research Corporation | AZG2 | Apr 17, 2025 | 2.54 | -2.31 |
AcadeMedia | V8T | Apr 17, 2025 | 7.12 | +2.59 |
Acadia Healthcare Company, Inc. | 7RA | Apr 17, 2025 | 21.00 | -8.70 |
ACADIA Pharmaceuticals Inc. | DR6 | Apr 17, 2025 | 12.81 | -1.31 |
Acadia Realty Trust | WX1 | Apr 17, 2025 | 17.50 | +3.55 |
Acadian Timber Corp | 779 | Apr 17, 2025 | 10.50 | 0.00 |
Acanthe Developpement SA | ADX | Apr 17, 2025 | 0.29 | -1.38 |
Acarix | 7AC | Apr 17, 2025 | 0.02 | +10.44 |
Acast AB | 0PN | Apr 17, 2025 | 1.16 | -2.03 |
Accelerate Diagnostics | 1A80 | Apr 17, 2025 | 0.48 | +0.84 |
ACCELLERON IND. ADR/1 | ZH20 | Apr 17, 2025 | 41.00 | -1.44 |
Accent Resources NL | A2R | Apr 17, 2025 | 0.01 | 0.00 |
Accentis S.A. | D1Z | Apr 17, 2025 | 0.03 | 0.00 |
Accentro Real Estate AG | A4Y | Apr 17, 2025 | 0.07 | -20.45 |
Accenture plc Class A Ordinary Shares (Ireland) | CSA | Apr 17, 2025 | 249.80 | -2.71 |
Accesso Technology Group Plc | LQG | Apr 17, 2025 | 4.80 | +2.13 |
Acciona SA | AJ3 | Apr 17, 2025 | 112.60 | -0.62 |
Acco Brands Corporation | A3B | Apr 17, 2025 | 3.16 | -2.47 |
Acconeer | 2LU | Apr 17, 2025 | 0.45 | +3.30 |
Accor | ACR1 | Apr 17, 2025 | 7.65 | -1.29 |
Accor SA | ACR | Apr 17, 2025 | 38.90 | -1.17 |
Accsys Technologies | 1D8 | Apr 17, 2025 | 0.51 | +1.20 |
Accuray Incorporated | XEJ | Apr 17, 2025 | 1.27 | -3.05 |
Ace Hardware Indonesia TBK | 4AH1 | Apr 17, 2025 | 0.02 | -42.86 |
ACE LIBERTY+STONE LS -,25 | 8MW | Apr 17, 2025 | 0.49 | +0.41 |
ACEA SpA | DCA | Apr 17, 2025 | 19.18 | +2.13 |
AcelRx Pharmaceuticals | R5XA | Apr 17, 2025 | 0.37 | -18.04 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.